The FDA Found Issue With Several NDAs in 2020, Partly Due to the COVID-19 Pandemic
COVID-19’s tentacles have invaded the New Drug Applications (NDAs) for 2020. A recent article in Fierce Pharma reported that the FDA has been especially vigilant in scrutinizing NDAs this year,…